- Home
- XPL vs DXR Comparison
XPL vs DXR Comparison
Compare XPL & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPL
- DXR
- Stock Information
- Founded
- XPL 1984
- DXR 1970
- Country
- XPL United States
- DXR United States
- Employees
- XPL N/A
- DXR N/A
- Industry
- XPL Precious Metals
- DXR Medical/Dental Instruments
- Sector
- XPL Basic Materials
- DXR Health Care
- Exchange
- XPL Nasdaq
- DXR Nasdaq
- Market Cap
- XPL 46.7M
- DXR 42.6M
- IPO Year
- XPL N/A
- DXR N/A
- Fundamental
- Price
- XPL $0.63
- DXR $8.31
- Analyst Decision
- XPL Strong Buy
- DXR Strong Buy
- Analyst Count
- XPL 2
- DXR 1
- Target Price
- XPL $1.60
- DXR $24.75
- AVG Volume (30 Days)
- XPL 55.3K
- DXR 38.6K
- Earning Date
- XPL 11-05-2024
- DXR 01-01-0001
- Dividend Yield
- XPL N/A
- DXR N/A
- EPS Growth
- XPL N/A
- DXR N/A
- EPS
- XPL N/A
- DXR 0.35
- Revenue
- XPL N/A
- DXR $154,205.00
- Revenue This Year
- XPL N/A
- DXR N/A
- Revenue Next Year
- XPL N/A
- DXR N/A
- P/E Ratio
- XPL N/A
- DXR $24.10
- Revenue Growth
- XPL N/A
- DXR N/A
- 52 Week Low
- XPL $0.43
- DXR $7.19
- 52 Week High
- XPL $0.98
- DXR $10.04
- Technical
- Relative Strength Index (RSI)
- XPL 54.87
- DXR 36.99
- Support Level
- XPL $0.56
- DXR $8.11
- Resistance Level
- XPL $0.71
- DXR $8.42
- Average True Range (ATR)
- XPL 0.04
- DXR 0.36
- MACD
- XPL 0.01
- DXR -0.13
- Stochastic Oscillator
- XPL 53.85
- DXR 0.53
About XPL Solitario Resources Corp.
Solitario Resources Corp is exploration company engaging in acquiring, exploring, and developing zinc properties and other precious metals in safe jurisdictions in North and South America. It has joint venture interests in large, high-grade zinc development projects. The Florida Canyon Zinc Project in Peru is a development asset held jointly with Nexa Resources S.A., Golden Crest Project in South Dakota and the Lik Zinc Project represents a large-tonnage, high-grade development project in Alaska in partnership with Teck Resources. In addition, the company has an additional portfolio of exploration properties and royalties in the Americas.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.